Biotest Aktiengesellschaft reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 215.2 million compared to EUR 117.2 million a year ago. Net income was EUR 29.5 million compared to net loss of EUR 20.4 million a year ago.

Basic earnings per share from continuing operations was EUR 0.74 compared to basic loss per share from continuing operations of EUR 0.53 a year ago.